form_8k-053002
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: May 30, 2002
Medix Resources, Inc.
(Exact name of registrant as specified in its charter)
Colorado 0-24768 84-1123311
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
420 Lexington Avenue, Suite 1830 , New York, NY 10170
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 697-2509
Item 5. Other Events. Press release dated May 30, 2002, announcing Medix
launches Georgia market initiatives.
Exhibits
99.1 Copy of Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIX RESOURCES, INC.
Date: May 30, 2002 By: /s/ Patricia A. Minicucci
Executive Vice President
Exhibit 99.1
Medix.resources, inc.
Connecting the world of healthcare
News Release
CONTACT:
John Prufeta
(212) 697-2509
(212) 681-9817 (fax)
Andrew Brown
(718) 323-7424
MEDIX LAUNCHES GEORGIA MARKET INITIATIVES
------
NEW YORK, May 30, 2002 - Medix Resources, Inc. (AMEX: MXR) today announced
the formal launch of market activities in the state of Georgia. The Georgia
launch marks the inaugural regional market for Medix. Under the leadership of
Southeast Market CEO Brian Ellacott, Medix has initiated core market development
activities including physician deployment and local health plan and PBM account
management. In addition, the regional operation will have responsibility for
local new account sales to secure locally based health plan, PBM and lab sponsor
agreements. Concurrent with the initiative is a targeted communications campaign
to key Georgia physician practices that includes direct mail marketing,
in-person presentations and phone solicitation.
John R. Prufeta, President and CEO of Medix commented, "This inaugural
market initiative in Georgia marks a significant point in the history of our
organization. Medix has assembled a core set of technologies that has gained the
acceptance of key PBM's and health plans, the sum which provided our Georgia
market team with a strong platform for growth. Our objective is clear - we will
organize our corporate and regional resources to aggressively deploy Cymedix(R)
technologies to enable participating physicians to reduce costly medical errors,
as well as simplify the administration of healthcare".
"Medix believes that success in the healthcare connectivity field is
established by providing technologies that encourage both initial physician
office adoption and provides a sufficient return that ensures the technology is
used over the long-term. We have established a dedicated regional operation in
Georgia that fosters a locally concentrated, relentless focus on physician
adoption, sponsor account growth and new sponsor sales", said Patricia
Minicucci, Medix Corporate Executive Vice President of Operations.
Brian Ellacott, Southeast Market CEO added, "My immediate goal is to fully
leverage and expand upon the early investment Medix has made in reaching out to
the key participants in the Georgia healthcare community. I look forward to
leading the charge to build our physician and sponsor relationships in the
Georgia marketplace".
About Medix Resources, Inc.
Medix Resources, Inc., through its wholly owned subsidiary Cymedix Lynx
Corporation, is the developer and provider of the Cymedix(R)suite of fully
secure, Internet based transaction software products, that enable communication
of high value added healthcare information among physician offices, hospitals,
health management organizations and health insurance companies. Additional
information about Medix Resources and its products and services can be found by
visiting its Web sites, WWW.MEDIXRESOURCES.COM and WWW.CYMEDIX.COM, or by
calling (800) 326-8773.
# # #
Information in this press release contains forward-looking statements that
involve risks and uncertainties that might adversely affect Medix's operating
results in the future to a material degree. Such risks and uncertainties
include, without limitation, the ability of Medix to raise capital to finance
the development of its software products, the effectiveness and the
marketability of those products, the ability of the Company to protect its
proprietary information, and the establishment of an efficient corporate
operating structure as the Company grows. These and other risks and
uncertainties are presented in detail in the Company's Form 10-K for 2001, which
was filed with the Securities and Exchange Commission on March 30, 2002 and the
Company's 10Q for the First Quarter of 2002, which was filed with the Securities
and Exchange Commission on May 15, 2002. This information is available from the
SEC or the Company.